Author:
Walsh Lance P.,Lotan Yair
Publisher
Oxford University Press (OUP)
Subject
Biochemistry, medical,Clinical Biochemistry
Reference83 articles.
1. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update;Partin, AW;JAMA,1997
2. Kattan MW, Shariat SF, Andrews B, et al. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer. J Clin Oncol. 2003;21:3573-3579.
3. Molecular markers of prostate cancer outcome;Quinn, DI;Eur J Cancer,2005
4. Using molecular markers to predict outcome;Rubin, MA;J Urol,2004
5. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends;Etzioni, R;J Natl Cancer Inst,2002